Literature DB >> 15614426

Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.

J Srinivasan1, W J Schmidt.   

Abstract

The alpha(2)-adrenoceptor antagonists potentiate both ipsilateral and contralateral rotations induced by amphetamine and apomorphine respectively in hemiparkinsonian rats. The present study investigated the role of serotonergic transmission in this potentiation in unilaterally 6-hydroxydopamine nigral lesioned rats. D-amphetamine (0.5 mg/kg, i.p.) produced ipsilateral rotations, which were decreased by the dopamine receptor antagonist haloperidol (0.2 mg/kg, i.p.) and the alpha(1)-receptor antagonist prazosin (1 mg/kg, i.p.). The selective alpha(2)-antagonist 2-methoxy idazoxan (0.2 mg/kg, i.p.) potentiated the amphetamine-induced ipsilateral rotations, that were attenuated by haloperidol and prazosin. The selective serotonin re-uptake inhibitor citalopram (10 mg/kg, i.p.) and selective serotonin synthesis inhibitor p-chlorophenylalanine (150 mg/kg, i.p., 3 days) decreased and increased the observed potentiation respectively. Apomorphine (0.2 mg/kg, s.c.) produced contralateral rotations, which were decreased by haloperidol but not by prazosin. 2-methoxy idazoxan potentiated these rotations which were attenuated by haloperidol but not by prazosin. Citalopram and p-chlorophenylalanine increased and decreased the observed potentiation respectively. Citalopram and p-chlorophenylalanine had no effect by per se on D-amphetamine and apomorphine-induced rotations. 2-methoxy idazoxan alone increased both ipsilateral and contralateral spontaneous rotations. Taken together, these findings indicate that an increase in noradrenergic tone by 2-methoxy idazoxan potentiates both D-amphetamine-induced ipsilateral and apomorphine induced contralateral rotations. alpha(1)-Antagonism attenuates D-amphetamine induced ipsilateral rotations and its potentiation by 2-methoxy idazoxan but not apomorphine rotations or its potentiation. Increasing and decreasing the serotonergic transmission decreases and increases D-amphetamine potentiation, whereas increases and decreases apomorphine potentiation respectively. The possible mechanisms for these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15614426     DOI: 10.1007/s00702-004-0259-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  61 in total

1.  Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist.

Authors:  J Sallinen; R E Link; A Haapalinna; T Viitamaa; M Kulatunga; B Sjöholm; E Macdonald; M Pelto-Huikko; T Leino; G S Barsh; B K Kobilka; M Scheinin
Journal:  Mol Pharmacol       Date:  1997-01       Impact factor: 4.436

2.  Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia.

Authors:  P E Bickler; B M Hansen
Journal:  Neuropharmacology       Date:  1996-06       Impact factor: 5.250

3.  Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.

Authors:  P Hertel; G G Nomikos; B Schilström; L Arborelius; T H Svensson
Journal:  Neuropsychopharmacology       Date:  1997-07       Impact factor: 7.853

4.  Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.

Authors:  P Hertel; M V Fagerquist; T H Svensson
Journal:  Science       Date:  1999-10-01       Impact factor: 47.728

5.  Basal ganglia outflow pathways and circling behaviour in the rat.

Authors:  P N Leigh; C Reavill; P Jenner; C D Marsden
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

6.  Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function.

Authors:  J C Garratt; F Crespi; R Mason; C A Marsden
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

7.  The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.

Authors:  Roberto W Invernizzi; Claudio Garavaglia; Rosario Samanin
Journal:  Neuropsychopharmacology       Date:  2003-03-19       Impact factor: 7.853

8.  The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.

Authors:  Antti Haapalinna; Tiina Leino; Esa Heinonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

9.  Effects of alpha 2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats.

Authors:  G Engberg; E Eriksson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

10.  Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo.

Authors:  R Tao; S Hjorth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

View more
  1 in total

1.  Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats.

Authors:  Virgili Pérez; Victoria Sosti; Antonia Rubio; Manel Barbanoj; Ignasi Gich; José Rodríguez-Alvarez; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2009-05-26       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.